The microRNA cluster miR-106-25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation

Department of Genetics, Stanford University School of Medicine
Aging (Impact Factor: 6.43). 02/2011; 3(2):108-24.
Source: PubMed


In adult mammals, neural stem cells (NSCs) generate new neurons that are important for specific types of learning and memory. Controlling adult NSC number and function is fundamental for preserving the stem cell pool and ensuring proper levels of neurogenesis throughout life. Here we study the importance of the microRNA gene cluster miR-106b~25 (miR-106b, miR-93, and miR-25) in primary cultures of neural stem/progenitor cells (NSPCs) isolated from adult mice. We find that knocking down miR-25 decreases NSPC proliferation, whereas ectopically expressing miR-25 promotes NSPC proliferation. Expressing the entire miR-106b~25 cluster in NSPCs also increases their ability to generate new neurons. Interestingly, miR-25 has a number of potential target mRNAs involved in insulin/insulin-like growth factor-1 (IGF) signaling, a pathway implicated in aging. Furthermore, the regulatory region of miR-106b~25 is bound by FoxO3, a member of the FoxO family of transcription factors that maintains adult stem cells and extends lifespan downstream of insulin/IGF signaling. These results suggest that miR-106b~25 regulates NSPC function and is part of a network involving the insulin/IGF-FoxO pathway, which may have important implications for the homeostasis of the NSC pool during aging.

29 Reads
    • "The production and/or aggregation of Aβ peptide is believed to play a central role in the pathogenesis of Alzheimer disease (AD). While the final effect might be directly linked to miR-106b effects on Abca1 rather than other target genes in neuronal cells (Kim et al. 2012), we should not discard other indirect effects as this miRNA also targets various other proteins related to cell proliferation and differentiation (Brett et al. 2011). Moreover, the amyloid precursor protein (APP) is also a target of miR-106b (Hebert et al. 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The specificity of Watson-Crick base pairing and the development of several chemical modifications to oligonucleotides have enabled the development of novel drug classes for the treatment of different human diseases. This review focuses on promising results of recent preclinical or clinical studies on targeting HDL metabolism and function by antisense oligonucleotides and miRNA-based therapies. Although many hurdles regarding basic mechanism of action, delivery, specificity, and toxicity need to be overcome, promising results from recent clinical trials and recent approval of these types of therapy to treat dyslipidemia suggest that the treatment of HDL dysfunction will benefit from these unique clinical opportunities. Moreover, an overview of monoclonal antibodies (mAbs) developed for the treatment of dyslipidemia and cardiovascular disease and currently being tested in clinical studies is provided. Initial studies have shown that these compounds are generally safe and well tolerated, but ongoing large clinical studies will assess their long-term safety and efficacy.
    Handbook of experimental pharmacology 01/2015; 224:649-89. DOI:10.1007/978-3-319-09665-0_22
  • Source
    • "Nonetheless, the regulation of the miR-106-25 cluster by FoxO3 is crucial to induce the expression of genes involved in the maintenance of quiescence, in the prevention of premature neural differentiation as well as in the control of oxygen metabolism of NSCs. In accordance with this, bioinformatic predictions suggest genes involved in the p53-, hypoxia-, TGFβ-, insulin/IGF-and nitric oxide-signaling as promising putative target genes for miR-25 (Renault et al., 2009; Brett et al., 2011). However, further experiments are required to validate these predictions and the physiological relevance of these interactions. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Development of the central nervous system (CNS) requires a precisely coordinated series of events. During embryonic development, different intra- and extracellular signals stimulate neural stem cells to become neural progenitors, which eventually irreversibly exit from the cell cycle to begin the first stage of neurogenesis. However, before this event occurs, the self-renewal and proliferative capacities of neural stem cells and neural progenitors must be tightly regulated. Accordingly, the participation of various evolutionary conserved microRNAs is key in distinct central nervous system (CNS) developmental processes of many organisms including human, mouse, chicken, frog, and zebrafish. microRNAs specifically recognize and regulate the expression of target mRNAs by sequence complementarity within the mRNAs 3' untranslated region and importantly, a single microRNA can have several target mRNAs to regulate a process; likewise, a unique mRNA can be targeted by more than one microRNA. Thus, by regulating different target genes, microRNAs let-7, microRNA-124, and microRNA-9 have been shown to promote the differentiation of neural stem cells and neural progenitors into specific neural cell types while microRNA-134, microRNA-25 and microRNA-137 have been characterized as microRNAs that induce the proliferation of neural stem cells and neural progenitors. Here we review the mechanisms of action of these two sets of microRNAs and their functional implications during the transition from neural stem cells and neural progenitors to fully differentiated neurons. The genetic and epigenetic mechanisms that regulate the expression of these microRNAs as well as the role of the recently described natural RNA circles which act as natural microRNA sponges regulating post-transcriptional microRNA expression and function during the early stages of neurogenesis is also discussed.
    Frontiers in Cellular Neuroscience 06/2014; 8:175. DOI:10.3389/fncel.2014.00175 · 4.29 Impact Factor
  • Source
    • "Most mammalian mRNAs are targeted by miRNAs and post-transcriptionally regulated through the presence of either conserved or non-conserved miRNA sites in their 3′ UTR [9]. Thus, numerous biological processes and functions are influenced by miRNAs, as evidenced by their involvement in regulating normal physiological as well as pathological conditions [10-12]. While as many as ~50% of mammalian mRNAs appear to be under selective pressure to maintain pairing to miRNAs through conserved sites [9], there are many more functional but non-conserved miRNA sites that can also potentially affect multiple biological processes [13-16]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: miRNAs are a major class of regulators of gene expression in metazoans. By targeting cognate mRNAs, miRNAs are involved in regulating most, if not all, biological processes in different cell and tissue types. To better understand how this regulatory potential is allocated among different target gene sets, we carried out a detailed and systematic analysis of miRNA target sites distribution in the mouse genome. We used predicted conserved and non-conserved sites for 779 miRNAs in 3[prime] UTR of 18440 genes downloaded from TargetScan website. Our analysis reveals that 3[prime] UTRs of genes encoding regulatory proteins harbor significantly greater number of miRNA sites than those of non-regulatory, housekeeping and structural, genes. Analysis of miRNA sites for orthologous 3[prime]UTR's in 10 other species indicates that the regulatory genes were maintaining or accruing miRNA sites while non-regulatory genes gradually shed them in the course of evolution. Furthermore, we observed that 3[prime] UTR of genes with higher gene expression variability driven by their promoter sequence content are targeted by many more distinct miRNAs compared to genes with low transcriptional noise. Based on our results we envision a model, which we dubbed "selective inclusion", whereby non-regulatory genes with low transcription noise and stable expression profile lost their sites, while regulatory genes which endure higher transcription noise retained and gained new sites. This adaptation is consistent with the requirements that regulatory genes need to be tightly controlled in order to have precise and optimum protein level to properly function.
    BMC Evolutionary Biology 04/2014; 14(1):74. DOI:10.1186/1471-2148-14-74 · 3.37 Impact Factor
Show more

Preview (3 Sources)

29 Reads
Available from